Published in Medicine and Law Weekly, August 3rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Teva Pharmaceutical Industries Ltd..
Report 1: Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced that the U.S. District Court for the District of New Jersey has vacated a temporary restraining order in effect since May 23, 2007 and denied a motion filed by Novartis for a preliminary injunction related to Teva's amlodipine besylate/ benazepril products, AB rated to Novartis' Lotrel(R). In reaching its opinion, the court found that Novartis was not likely to succeed on its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.